Literature DB >> 20103296

Pulmonary endarterectomy improves dyspnea by the relief of dead space ventilation.

Mart N van der Plas1, Herre J Reesink, Carel M Roos, Reindert P van Steenwijk, Jaap J Kloek, Paul Bresser.   

Abstract

BACKGROUND: In chronic thromboembolic pulmonary hypertension (CTEPH), dyspnea is considered to be related to increased dead space ventilation caused by vascular obstruction. Pulmonary endarterectomy releases the thromboembolic obstruction, thereby improving regional pulmonary blood flow. We hypothesized that pulmonary endarterectomy reduces dead space ventilation and that this reduction contributes to attenuation of dyspnea symptoms.
METHODS: In this follow-up study we assessed dead space ventilation, hemodynamic severity of disease, and symptomatic dyspnea in 54 consecutive CTEPH patients, before and 1 year after pulmonary endarterectomy. Dead space ventilation was calculated using the Bohr-Enghoff equation. Dyspnea was assessed by Borg scores and the New York Heart Association functional classification.
RESULTS: Preoperatively, dead space ventilation was increased (0.40 +/- 0.07) and correlated with severity of disease (mean pulmonary artery pressure: r = 0.49, p < 0.001; total pulmonary resistance: r = 0.53, p < 0.001), and resting (r = 0.35, p < 0.05) and post-exercise Borg dyspnea scores (r = 0.44, p < 0.01). Postoperatively, dead space ventilation (0.33 +/- 0.08, p < 0.001) and dyspnea symptoms decreased significantly. Changes in symptomatic dyspnea were independently associated with changes in pulmonary hemodynamics and absolute dead space.
CONCLUSIONS: Dead space ventilation in CTEPH is increased and correlates significantly with hemodynamic severity of disease and dyspnea symptoms. Pulmonary endarterectomy decreases dead space ventilation. The induced change in dead space upon surgical removal of chronic thromboembolism contributes to the postoperative recovery of symptomatic dyspnea. 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20103296     DOI: 10.1016/j.athoracsur.2009.08.001

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  14 in total

Review 1.  Recognizing pulmonary hypertension following pulmonary thromboendarterectomy: A practical guide for clinicians.

Authors:  Paul Forfia; Bruce Ferraro; Anjali Vaidya
Journal:  Pulm Circ       Date:  2022-06-07       Impact factor: 2.886

Review 2.  Chronic thromboembolic pulmonary hypertension: diagnosis, operability assessment and patient selection for pulmonary endarterectomy.

Authors:  Tom Verbelen; Laurent Godinas; Geert Maleux; Johan Coolen; Guido Claessen; Catharina Belge; Bart Meyns; Marion Delcroix
Journal:  Ann Cardiothorac Surg       Date:  2022-03

Review 3.  Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes.

Authors:  David S Poch; William R Auger
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

4.  Cardiopulmonary exercise testing suggests a beneficial response to pulmonary endarterectomy in a patient with chronic thromboembolic obstruction and normal preoperative pulmonary hemodynamics.

Authors:  Colm McCabe; Stephen D Preston; Deepa Gopalan; John Dunning; Joanna Pepke-Zaba
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017

5.  Bosentan treatment is associated with improvement of right ventricular function and remodeling in chronic thromboembolic pulmonary hypertension.

Authors:  Sulaiman Surie; Herre J Reesink; J Tim Marcus; Mart N van der Plas; Jaap J Kloek; Anton Vonk-Noordegraaf; Paul Bresser
Journal:  Clin Cardiol       Date:  2013-08-27       Impact factor: 2.882

Review 6.  Respiratory and hemodynamic changes in patients with chronic thromboembolic pulmonary hypertension 1 year after pulmonary endarterectomy.

Authors:  Masato Sato; Motomi Ando; Kan Kaneko; Yoshiro Higuchi; Hiroshi Kondo; Kiyotoshi Akita; Michiko Ishida; Yasushi Takagi
Journal:  Ann Vasc Dis       Date:  2013-08-12

7.  Right ventricular dysfunction in chronic thromboembolic obstruction of the pulmonary artery: a pressure-volume study using the conductance catheter.

Authors:  Colm McCabe; Paul A White; Stephen P Hoole; Richard G Axell; Andrew N Priest; Deepa Gopalan; Dolores Taboada; Robert MacKenzie Ross; Nicholas W Morrell; Leonard M Shapiro; Joanna Pepke-Zaba
Journal:  J Appl Physiol (1985)       Date:  2013-12-19

8.  Evaluation of patients with chronic thromboembolic pulmonary hypertension for pulmonary endarterectomy.

Authors:  William R Auger; Kim M Kerr; Nick H Kim; Peter F Fedullo
Journal:  Pulm Circ       Date:  2012 Apr-Jun       Impact factor: 3.017

9.  Chronic thromboembolic pulmonary hypertension.

Authors:  B E Schölzel; R J Snijder; J J Mager; H W van Es; H W M Plokker; H J Reesink; W J Morshuis; M C Post
Journal:  Neth Heart J       Date:  2014-12       Impact factor: 2.380

10.  The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Manuel Jonas Richter; Katrin Milger; Sarah Haase; Natascha Sommer; Khodr Tello; Werner Seeger; Eckhard Mayer; Christoph Benjamin Wiedenroth; Friedrich Grimminger; Wolfgang George; Hossein Ardeschir Ghofrani; Stefan Guth; Henning Gall
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.